CureMatch, Inc.

About

CureMatch, Inc. is a healthcare technology company based in San Diego, founded in 2015. The company focuses on precision oncology and utilizes AI-driven decision support systems to enhance personalized cancer treatment. CureMatch was established following CEO Blaise Barrelet’s personal experience with leukemia and in collaboration with UC San Diego’s Moores Cancer Center and the San Diego Supercomputer Center. CureMatch offers a decision support platform that provides oncologists with predictive treatment analysis by integrating genomic, proteomic, and clinical data. This platform generates ranked combinations of targeted therapies to optimize patient outcomes. The company also analyzes FFPE tissue samples for molecular insights and employs an AI platform to improve drug combinations, aiming to enhance progression-free survival rates. CureMatch collaborates with various healthcare entities to streamline patient care workflows and expand access to precision medicine. Its mission is to replace standard cancer treatments with personalized therapies based on individual molecular profiles.